Follow-up results of combined treatment of non-small lung cancer

被引：0
|
作者：
Jackevicius, A [1 ]
Cicenas, S [1 ]
Piscikas, D [1 ]
Aleknavicius, E [1 ]
Ciceniene, A [1 ]
机构：
[1] Vilnius State Univ, Inst Oncol, Vilnius, Lithuania
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [21] Recurrence Dynamic of Completely Resected Non-Small Cell Lung Cancer in Perspective of Follow-Up Surveillance
    Kim, Eung Rae
    Park, In Kyu
    Hyun, Kwanyong
    Park, Samina
    Hwang, Yoohwa
    Kang, Chang Hyun
    Kim, Young Tae
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1395 - S1395
  • [22] RESULTS OF DIAGNOSIS AND TREATMENT FOR SMALL-CELL LUNG-CANCER IDENTIFIED IN THE COURSE OF FOLLOW-UP
    DENISOV, LY
    ODINTSOV, SV
    VOLODIN, VD
    ZAYEVA, NN
    VOPROSY ONKOLOGII, 1989, 35 (02) : 163 - 167
  • [23] Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
    Li, Xiongfei
    Fan, Fanfan
    Yang, Zijiang
    Huang, Qingyuan
    Fu, Fangqiu
    Zhang, Yang
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5729 - 5737
  • [24] Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer
    Salomaa, ER
    Liippo, K
    Ellmen, J
    Komi, J
    LUNG CANCER, 1996, 16 (01) : 75 - 80
  • [25] Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
    Zhao, Chenchen
    Yan, Haifeng
    Pang, Wentai
    Wu, Tong
    Kong, Xianbin
    Li, Xiaojiang
    Liu, Honggen
    Zhao, Linlin
    Liang, Feng
    Jia, Yingjie
    MEDICINE, 2021, 100 (12)
  • [26] Follow-up Analysis Enhances Understanding of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, Jia-Tao
    Liu, Si-Yang
    Gao, Xuan
    Liu, Si-Yang Maggie
    Yan, Bingfa
    Huang, Chen
    Jiao, Zicong
    Yan, Hong-Hong
    Pan, Yi
    Dong, Song
    Gao, Wei
    Gong, Yuhua
    Tu, Hai-Yan
    Xia, Xue-Feng
    Zhou, Qing
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Yi, Xin
    Wu, Yi-Long
    CLINICAL CANCER RESEARCH, 2025, 31 (07) : 1305 - 1314
  • [27] Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer
    Weitberg, AB
    Liu, L
    Yashar, J
    Glicksman, AS
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2001, 20 (03): : 335 - 340
  • [28] Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
    Barak, Vivian
    Holdenrieder, Stefan
    Nisman, Benjamin
    Stieber, Petra
    CANCER BIOMARKERS, 2010, 6 (3-4) : 191 - 196
  • [29] Alternative Follow-Up Methods Based on Recurrence Patterns after Surgery for Non-Small Cell Lung Cancer
    Watanabe, Katsuya
    Sakamaki, Kentaro
    Nishii, Teppei
    Gorai, Atsuo
    Yamamoto, Taketsugu
    Nagashima, Takuya
    Ando, Kohei
    Ishikawa, Yoshihiro
    Woo, Tetsukan
    Adachi, Hiroyuki
    Kumakiri, Yutaka
    Maehara, Takamitsu
    Nakayama, Haruhiko
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S245 - S246
  • [30] The Role of MonoTotal in the Primary Diagnosis, Prognosis and Follow-up of Patients with Non-small Cell Lung Cancer (NSCLC)
    Prazakova, Marketa
    Vrzalova, Jindra
    Maria Auge, Josep
    Safranek, Jarmil
    Topolcan, Ondrej
    Fuchsova, Radka
    Spisakova, Marketa
    Svobodova, Sarka
    Holubec, Lubos, Jr.
    Pesta, Martin
    ANTICANCER RESEARCH, 2011, 31 (09) : 3107 - 3112
12345